$0.000001
At close: May 5, 12:06 PM EDT
Comments
Loading...
RVL Pharmaceuticals Analyst Ratings and Price Targets | OTC:RVLPQ | Benzinga
RVL Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for RVL Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for RVL Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for RVL Pharmaceuticals (RVLPQ) stock?
There is no price target for RVL Pharmaceuticals
What is the most recent analyst rating for RVL Pharmaceuticals (RVLPQ)?
There is no analyst for RVL Pharmaceuticals
When was the last upgrade for RVL Pharmaceuticals (RVLPQ)?
There is no last upgrade for RVL Pharmaceuticals
When was the last downgrade for RVL Pharmaceuticals (RVLPQ)?
There is no last downgrade for RVL Pharmaceuticals.
When is the next analyst rating going to be posted or updated for RVL Pharmaceuticals (RVLPQ)?
There is no next analyst rating for RVL Pharmaceuticals.
Is the Analyst Rating RVL Pharmaceuticals (RVLPQ) correct?
There is no next analyst rating for RVL Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
